Many human tumors are resistant to immunotherapy because they downregulate STING signaling by various mechanisms,56,57 a fact that testifies to the importance of the cGAS-STING pathway in mediating tumor response to ICB therapy. This evidence concerns the gene STING1 and neoplasm.